Search

Novel TiO2 nanoparticles-coated CNTs (TiO2@CNTs) fabricated by the alcohol-thermal method were used as the reinforcement to prepare aluminum matrix composites through high-intensity ultrasonic-assisted casting, followed by heat treatment. The results of optical microscope showed that the optimum heat treatment process was solution treatment (495 °C, 2 h) + aging treatment (180 °C, 12 h). Under this condition, the Al2Cu and Al2CuMg phases were uniformly precipitated in the composites, and most of them were in a discrete state. TEM results revealed that TiO2 nanoparticles dispersed on the surface of CNTs played the role of an interlayer structure between CNTs and matrix, locking the CNTs and improving the CNTs–Al interfacial bonding. The ultimate tensile strength (UTS) and yield strength (YS) of 1.0 wt%TiO2@CNTs/2024 composite after T6 heat treatment reach 324 MPa and 219 MPa, respectively, which exhibited enhanced UTS and YS than the monolithic 2024 alloy. This was attributed to the synergistic strengthening of multi-mechanisms, such as grain refinement strengthening, load transfer strengthening, dislocation strengthening and, especially, Orowan strengthening. [ABSTRACT FROM AUTHOR]

Lonicera japonica Thunb, rich in chlorogenic acid (CHA), is used for viral upper respiratory tract infection treatment caused by influenza virus, parainfluenza virus, and respiratory syncytial virus, ect in China. It was reported that CHA reduced serum hepatitis B virus level and death rate of influenza virus-infected mice. However, the underlying mechanisms of CHA against the influenza A virus have not been fully elucidated. Here, the antiviral effects and potential mechanisms of CHA against influenza A virus were investigated. CHA revealed inhibitory against A/PuertoRico/8/1934(H1N1) (EC50 = 44.87 μM), A/Beijing/32/92(H3N2) (EC50 = 62.33 μM), and oseltamivir-resistant strains. Time-course analysis showed CHA inhibited influenza virus during the late stage of infectious cycle. Indirect immunofluorescence assay indicated CHA down-regulated the NP protein expression. The inhibition of neuraminidase activity confirmed CHA blocked release of newly formed virus particles from infected cells. Intravenous injection of 100 mg/kg/d CHA possessed effective antiviral activity in mice, conferring 60% and 50% protection from death against H1N1 and H3N2, reducing virus titres and alleviating inflammation in the lungs effectively. These results demonstrate that CHA acts as a neuraminidase blocker to inhibit influenza A virus both in cellular and animal models. Thus, CHA has potential utility in the treatment of the influenza virus infection. [ABSTRACT FROM AUTHOR]